Home > Insider Trading > Filing (0001127602-17-012558)

Filing Details

Accession Number:: 0001127602-17-012558
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-21 18:07:25
Reporting Period:: 2017-03-20

Filing Date:: 2017-03-21
Accepted Time:: 2017-03-21 18:07:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1613103	Medtronic Plc	MDT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610036	Rob Hoedt Ten	710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432	Evp & President Emea	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2017-03-20	8,154	$37.53	59,392	No	4	M	Direct
Ordinary Shares	Acquisiton	2017-03-20	21,129	$38.81	80,521	No	4	M	Direct
Ordinary Shares	Acquisiton	2017-03-20	10,357	$62.76	90,878	No	4	M	Direct
Ordinary Shares	Acquisiton	2017-03-20	11,117	$55.32	101,995	No	4	M	Direct
Ordinary Shares	Disposition	2017-03-20	50,757	$81.58	51,238	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2017-03-20	8,154	$0.00	8,154	$37.53
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2017-03-20	21,129	$0.00	21,129	$38.81
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2017-03-20	10,357	$0.00	10,357	$62.76
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2017-03-20	11,117	$0.00	11,117	$55.32

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2020-08-02	No	4	M	Direct
0	2022-07-30	No	4	M	Direct
11,951	2024-07-28	No	4	M	Direct
5,514	2023-07-29	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.301 to $82.098, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
This balance increased by 386 shares due to exempt transactions such as dividend reinvestment.
This option to purchase 8,154 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 8,154 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
This option to purchase 21,129 New Medtronic ordinary shares for $38.81per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 21,129 Medtronic common stock shares for $38.81per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
This option to purchase 20,714 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 20,714 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
This option to purchase 14,823 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 14,823 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.